{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-26-000006","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.717182+00:00","generated_at":"2026-05-15T22:40:30.310936+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Surgery Partners Q4 rev $885M (+2.4%), Adj. EBITDA $156.9M (-4.2%), net loss $15M, 2026 guidance, $200M buyback","bullets":["Revenue $885.0M (+2.4% YoY); full-year $3.3B (+6.2%). Same-facility revenue +3.5% Q4.","Adj. EBITDA $156.9M (-4.2% YoY); full-year $526.2M (+3.5%). Net loss $15.0M Q4, $77.9M FY.","2026 guidance: Adj. EBITDA at least $530M; revenue range $3.35B-$3.45B.","Board authorized $200M share repurchase program on February 26, 2026.","Operating cash flow $103.4M Q4 (down from $111.4M); net debt/EBITDA ~4.3x."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-26-000006","json":"https://secwatch.observer/filing/0001638833-26-000006.json","markdown":"https://secwatch.observer/filing/0001638833-26-000006.md","text":"https://secwatch.observer/filing/0001638833-26-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883326000006/0001638833-26-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883326000006/sgry-20260302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:40:30.310936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}